(Q44767956)

6 December 2017

Immune functions in healthy blood donors with HLA-DW2 and -DW3 antigens (English)

1 reference

6 December 2017

Ilonen J

1

1 reference

6 December 2017

Salonen R

2

1 reference

6 December 2017

Hyypiä T

3

1 reference

6 December 2017

Lankinen K

4

1 reference

6 December 2017

Karttunen R

5

1 reference

6 December 2017

Salmi A

6

1 reference

6 December 2017

1 July 1986

1 reference

6 December 2017

1 reference

6 December 2017

171

1 reference

6 December 2017

388-399

1 reference

6 December 2017

4-5

1 reference

Multiple Sclerosis as a Disease of Immune Regulation

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

The genetics of susceptibility to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Immunoglobulins in multiple sclerosis and infections of the nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Multiple sclerosis and viruses: An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Letter: Lymphocyte transformation in vitro to paramyxovirus antigens in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Decreased lymphocyte transformation to vaccinia virus in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Cellular immune response to measles, mumps, and vaccinia viruses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Cell-mediated immunity to viral antigens and tuberculin in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

PPD-, PWM-, and PHA-induced interferon in stable multiple sclerosis: association with HLA-Dw2 antigen and clinical variables

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Defective production of interferon-alpha associated with HLA-DW2 antigen in stable multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Association between HL-A antigens and measles antibody in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Measles antibodies as related to HL-A types in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Measles antibody titers in multiple sclerosis patients and HLA-matched and unmatched siblings

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Letter: HL-A 3,7 and lymphocyte cytotoxic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Association between HLA B7,DR2 and dysfunction of natural- and antibody- mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Intrathecal synthesis of virus antibodies in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Pronounced antiviral activity of human interferon on bovine and porcine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

HLA-D Region Molecules Restrict Proliferative T Cell Responses to Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Multiple sclerosis: Relation of in vitro IgG secretion to T suppressor cell number and function

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980071-7

7 January 2021

10.1016/S0171-2985(86)80071-7

Identifiers

DOI

0 references

1 reference